Development and characterization of new contrast agents for Photon-Counting CT

The visualization and characterization of benign and malignant structures using computed tomography (CT) is an integral part of clinical routine and thus, CT is one of the most important non-invasive imaging modalities available today [1–4]. The number of CT scans performed each year is approximately 300 million with an annual growth rate of 4 % [1]. A disadvantage of the current CT imaging technology, however, is the detection of the X-rays, which is conventionally performed using energy-integr…

Read the full article on ejradiology.com